We are live on ! Find out more
BBH icon

VanEck Biotech ETF

106 hedge funds and large institutions have $109M invested in VanEck Biotech ETF in 2025 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 13 increasing their positions, 39 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

333% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 3

8% more funds holding

Funds holding: 98106 (+8)

4.88% less ownership

Funds ownership: 34.84%29.97% (-4.9%)

6% less capital invested

Capital invested by funds: $115M → $109M (-$6.74M)

67% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 39

69% less call options, than puts

Call options by funds: $232K | Put options by funds: $746K

Holders
106
Holders Change
+8
Holders Change %
+8.16%
% of All Funds
1.39%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
13
Reduced
39
Closed
3
Calls
$232K
Puts
$746K
Net Calls
-$514K
Net Calls Change
-$146K
Name Holding Trade Value Shares
Change
Change in
Stake
Corient Private Wealth
26
Corient Private Wealth
Florida
$829K -$267K -1,640 -25%
CIBC Private Wealth Group
27
CIBC Private Wealth Group
Georgia
$821K
PSF
28
Pacific Sun Financial
California
$703K -$24.5K -150 -3%
PNC Financial Services Group
29
PNC Financial Services Group
Pennsylvania
$663K
NWA
30
Navis Wealth Advisors
New York
$659K
AL
31
Aspiriant LLC
California
$618K
KAS
32
Kestra Advisory Services
Texas
$552K -$32.4K -199 -6%
PAW
33
Plan A Wealth
Nebraska
$511K -$646K -3,962 -56%
Janney Montgomery Scott
34
Janney Montgomery Scott
Pennsylvania
$487K -$20.4K -125 -4%
Citadel Advisors
35
Citadel Advisors
Florida
$473K -$865K -5,307 -65%
JP Morgan Chase
36
JP Morgan Chase
New York
$467K -$241K -1,480 -34%
Citigroup
37
Citigroup
New York
$439K -$462K -2,832 -52%
Jones Financial Companies
38
Jones Financial Companies
Missouri
$413K -$3.59K -22 -0.9%
Wealth Enhancement Advisory Services
39
Wealth Enhancement Advisory Services
Minnesota
$396K
WJWM
40
Williams Jones Wealth Management
New York
$364K
PVI
41
Pine Valley Investments
New Jersey
$356K
Cetera Investment Advisers
42
Cetera Investment Advisers
Illinois
$354K +$17.1K +105 +5%
Northern Trust
43
Northern Trust
Illinois
$351K +$346K +2,120 New
TYCC
44
Texas Yale Capital Corp
Florida
$345K
Jane Street
45
Jane Street
New York
$331K +$326K +2,000 New
BFC
46
Blue Fin Capital
Rhode Island
$260K
BCV
47
Banque Cantonale Vaudoise
Switzerland
$254K +$53.2K +326 +27%
HFAS
48
Hummer Financial Advisory Services
Illinois
$234K
RSWM
49
Robertson Stephens Wealth Management
California
$232K
Creative Planning
50
Creative Planning
Kansas
$231K +$2.45K +15 +1%

BBH Hedge Fund Activity: Q3 2025 in Review

106 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q3 2025, worth a combined $109M — down 5.8% from $115M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new BBH positions and 3 closed out — a net gain of 10 holders — while 13 added to existing stakes and 39 trimmed.

The largest buyer was Paragon Private Wealth Management, adding an estimated $1.51M. The largest seller was TD Waterhouse Canada, cutting an estimated $10.5M.

  • 106 institutional investors held VanEck Biotech ETF (BBH) as of Q3 2025, up from 98 in Q2 2025.
  • Funds reported $109M of VanEck Biotech ETF stock for Q3 2025, down 5.8% quarter-over-quarter.
  • 13 funds opened new VanEck Biotech ETF positions in Q3 2025 and 3 closed out, a net change of +10 holders.
  • The largest VanEck Biotech ETF buyer in Q3 2025 was Paragon Private Wealth Management, an estimated $1.51M added.
  • The largest VanEck Biotech ETF seller in Q3 2025 was TD Waterhouse Canada, an estimated $10.5M sold.

Based on aggregated 13F filings for Q3 2025.